Mechanism of a transcriptional cross talk between transforming growth factor-β-regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4

Molecular Biology of the Cell

Volumn 14, Issue 3, 2003, Pages 1279-1294

  Chou, Wan Chih ^a   Prokova, Vassiliki ^a   Shiraishi, Keiko ^b   Valcourt, Ulrich ^b   Moustakas, Aristidis ^b   Hadzopoulou Cladaras, Margarita ^c   Zannis, Vassilis I ^a   Kardassis, Dimitris ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; DNA; GLUTATHIONE TRANSFERASE; HEPATOCYTE NUCLEAR FACTOR 4; HYBRID PROTEIN; LUCIFERASE; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRUS; ARTICLE; DNA BINDING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION;

ANIMALS; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINE; COUP TRANSCRIPTION FACTOR I; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, GLUCOCORTICOID; RECEPTORS, STEROID; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRIDAE; DNA VIRUSES;

EID: 0037346882     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E02-07-0375     Document Type: Article

References (50)

1. Chambon, P. (1996). A decade of molecular biology of retinoic acid receptors FASEB J. 10, 940-954.
2. Chipuk, J.E., Cornelius, S.C., Pultz, N.J., Jorgensen, J.S., Bonham, M.J., and Kim, S.J., and Danielpour, D. (2002). The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3. J. Biol. Chem. 277, 1240-1248.
3. de Winter JP, Roelen BA, ten Dijke P, van der Burg B, and van den Eijnden-van Raaij AJ. (1997). DPC4 (SMAD4) mediates transforming growth factor-beta1 (TGF-beta1) induced growth inhibition and transcriptional response in breast tumour cells Oncogene 14, 1891-1899.
4. Dell, H., and Hadzopoulou-Cladaras, M. (1999). CREB-binding protein is a transcriptional coactivator for hepatocyte nuclear factor-4 and enhances apolipoprotein gene expression. J. Biol. Chem. 274, 9013-9021.
5. Dennler, S., Huet, S., and Gauthier, J.M. (1999). A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene 18, 1643-1648.
6. Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S., and Gauthier, J.M. (1998). Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100.
7. Feng, X.H., Zhang, Y., Wu, R.Y., and Derynck, R. (1998). The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. Genes Dev. 12, 2153-2163.
8. Fujii, M., Takeda, K., Imamura, T., Aoki, H., Sampath, T.K., Enomoto, S., Kawabata, M., Kato, M., Ichijo, H., and Miyazono, K. (1999). Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell 10, 3801-3813.
9. Glass, C.K., and Rosenfeld, M.G. (2000). The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14, 121-141.
10. Hadzopoulou-Cladaras, M., Kistanova, E., Evagelopoulou, C., Zeng, S., Cladaras, C., and Ladias, J.A. (1997). Functional domains of the nuclear receptor hepatocyte nuclear factor 4. J. Biol. Chem. 272, 539-550.
11. Hayes, S.A., Zarnegar, M., Sharma, M., Yang, F., Peehl, D.M., ten Dijke, P., and Sun, Z. (2001). SMAD3 represses androgen receptor-mediated transcription. Cancer Res 61, 2112-2118.
12. Hayhurst, G.P., Lee, Y.H., Lambert, G., Ward, J.M., and Gonzalez, F.J. (2001). Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell. Biol. 21, 1393-1403.
13. Heldin, C.H., Miyazono, K., and ten Dijke, P. (1997). TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
14. Itoh, S., Itoh, F., Goumans, M.J., and ten Dijke, P. (2000). Signaling of transforming growth factor-beta family members through Smad proteins. Eur. J. Biochem. 267, 6954-6967.
15. Janknecht, R., Wells, N.J., and Hunter, T. (1998). TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300. Genes Dev. 12, 2114-2119.
16. Kardassis, D., Hadzopoulou-Cladaras, M., Ramji, D.P., Cortese, R., Zannis, V.I., and Cladaras, C. (1990). Characterization of the promoter elements required for hepatic and intestinal transcription of the human apoB gene: definition of the DNA-binding site of a tissue-specific transcriptional factor. Mol. Cell. Biol. 10, 2653-2659.
17. Kardassis, D., Pardali, K., and Zannis, V.I. (2000). SMAD proteins transactivate the human ApoCIII promoter by interacting physically and functionally with hepatocyte nuclear factor 4. J. Biol. Chem. 275, 41405-41414.
18. Kistanova, E., Dell, H., Tsantili, P., Falvey, E., Cladaras, C., and Hadzopoulou-Cladaras, M. (2001). The activation function-1 of hepatocyte nuclear factor-4 is an acidic activator that mediates interactions through bulky hydrophobic residues. Biochem. J. 356, 635-642.
19. Ktistaki, E., Lacorte, J.M., Katrakili, N., Zannis, V.I., and Talianidis, I. (1994). Transcriptional regulation of the apolipoprotein A-IV gene involves synergism between a proximal orphan receptor response element and a distant enhancer located in the upstream promoter region of the apolipoprotein C-III gene. Nucleic Acids Res. 22, 4689-4696.
20. Ladias, J.A.A., Hadzopoulou-Cladaras, M., Kardassis, D., Cardot, P., Cheng, J., Zannis, V.I., and Cladaras, C. (1992). Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. J. Biol. Chem. 267, 15849-15860.
21. Mizushima, S., and Nagata, S. (1990). pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18, 5322.
22. Lavrentiadou, S.N., Hadzopoulou-Cladaras, M., Kardassis, D., and Zannis, V.I. (1999). Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors. Biochemistry 38, 964-975.
23. Li, J., Ning, G., and Duncan, S.A. (2000). Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev. 14, 464-474.
24. Mangelsdorf, D.J., and Evans, R.M. (1995). The RXR heterodimers and orphan receptors. Cell 83, 841-850.
25. Massague, J., and Wotton, D. (2000). Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19, 1745-1754.
26. Massague, J. (1998). TGF-beta signal transduction. Annu. Rev. Biochem. 67, 753-791.
27. Matsuda, T., Yamamoto, T., Muraguchi, A., and Saatcioglu, F. (2001). Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3. J. Biol. Chem. 276, 42908-42914.
28. Moras, D., and Gronemeyer, H. (1998). The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10, 384-391.
29. Moren, A., Itoh, S., Moustakas, A., Dijke, P., and Heldin, C.H. (2000). Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4. Oncogene 19, 4396-4404.
30. Moustakas, A., Souchelnytskyi, S., and Heldin, C.H. (2001). Smad regulation in TGF-beta signal transduction. J. Cell Sci. 114, 4359-4369.
31. Moustakas, A., and Kardassis, D. (1998). Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA 95, 6733-6738.
32. Pardali, K., Kurisaki, A., Morén, A., ten Dijke, P., Kardassis, D., and Moustakas, A. (2000). Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J. Biol. Chem. 275, 29244-29256.
33. Peters, G.A., and Khan, S.A. (1999). Estrogen receptor domains E and F: role in dimerization and interaction with coactivator RIP-140. Mol. Endocrinol. 13, 286-296.
34. Piek, E., Moustakas, A., Kurisaki, A., Heldin, C.-H., and ten Dijke, P. (1999). TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J. Cell Sci. 112, 4557-4568.
35. Pouponnot, C., Jayaraman, L., and Massague, J. (1998). Physical and functional interaction of SMADs and p300/CBP. J. Biol. Chem. 273, 22865-22868.
36. Shao, D., and Lazar, M.A. (1999). Modulating nuclear receptor function: may the phos be with you. J. Clin. Invest. 103, 1617-1618.
37. Shi, Y. (2001). Structural insights on Smad function in TGFbeta signaling. Bioessays 23, 223-232.
38. Sladek, F.M. (1993). Orphan receptor HNF-4 and liver-specific gene expression. Receptor 3, 223-232.
39. Sladek, F.M., Ruse, M.D., Jr., Nepomuceno, L., Huang, S.M., and Stallcup, M.R. (1999). Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1. Mol. Cell. Biol. 19, 6509-6522.
40. Song, C.Z., Tian, X., and Gelehrter, T.D. (1999). Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3. Proc. Natl. Acad. Sci. USA 96, 11776-11781.
41. Soutoglou, E., Katrakili, N., and Talianidis, I. (2000). Acetylation regulates transcription factor activity at multiple levels. Mol. Cell 5, 745-751
42. ten Dijke, P., Miyazono, K., and Heldin, C.-H. (2000). Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem. Sci. 25, 64-70.
43. Tsai, M.J., and O'Malley, B.W. (1994). Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486.
44. Tzameli, I., and Zannis, V.I. (1996). Binding specificity and modulation of the ApoA-I promoter activity by homo- and heterodimers of nuclear receptors. J. Biol. Chem. 271, 8402-8415.
45. Valcourt, U., Gouttenoire, J., Moustakas, A., Herbage, D., and Mallein-Gerin, F. (2002). Functions of transforming growth factor-beta family type I receptors and Smad proteins in the hypertrophic maturation and osteoblastic differentiation of chondrocytes. J. Biol. Chem. 277, 33545-33558.
46. Yagi, K., Goto, D., Hamamoto, T., Takenoshita, S., Kato, M., and Miyazono, K. (1999). Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3. J. Biol. Chem. 274, 703-709.
47. Yanagi, Y., Suzawa, M., Kawabata, M., Miyazono, K., Yanagisawa, J., and Kato, S. (1999). Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins. J. Biol. Chem. 274, 12971-12974.
48. Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Suzawa, M., Watanabe, M., Kashiwagi, K., Toriyabe, T., Kawabata, M., Miyazono, K., and Kato, S. (1999). Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283, 1317-1321.
49. Zannis, V.I., Kan, H.Y., Kritis, A., Zanni, E.E., and Kardassis, D. (2001). Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo. Curr. Opin. Lipidol. 12, 181-207.
50. Zhang, Y., Musci, T., and Derynck, R. (1997). The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Curr. Biol. 7, 270-276.